{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:17:28Z","timestamp":1790399848124,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.tox.2006.11.069","type":"journal-article","created":{"date-parts":[[2006,12,3]],"date-time":"2006-12-03T07:12:21Z","timestamp":1165129941000},"page":"60-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Sensitivity of butyrylcholinesterase knockout mice to (\u2212)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission"],"prefix":"10.1016","volume":"233","author":[{"given":"Ellen G.","family":"Duysen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan","family":"Darvesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Lockridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2006.11.069_bib1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-5793(90)80300-8","article-title":"Role of butyrylcholinesterase in canine tracheal smooth muscle function","volume":"267","author":"Adler","year":"1990","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tox.2006.11.069_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/mus.20099","article-title":"Reduced acetylcholine receptor density, morphological remodeling, and butyrylcholinesterase activity can sustain muscle function in acetylcholinesterase knockout mice","volume":"30","author":"Adler","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.tox.2006.11.069_bib3","first-page":"121","article-title":"Prophylaxis against soman inhalation toxicity in guinea pigs by pretreatment alone with human serum butyrylcholinesterase","volume":"43","author":"Allon","year":"1998","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2006.11.069_bib4","series-title":"Practical Statistics For Medical Research","author":"Altman","year":"1999"},{"key":"10.1016\/j.tox.2006.11.069_bib5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0006-291X(92)90649-6","article-title":"Mechanism of inhibition of cholinesterases by huperzine A","volume":"184","author":"Ashani","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tox.2006.11.069_bib6","first-page":"1086","article-title":"DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites","volume":"50","author":"Bartels","year":"1992","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tox.2006.11.069_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pbb.2004.10.014","article-title":"Effects of acetylcholinesterase and butyrylcholinesterase inhibition on breathing in mice adapted or not to reduced acetylcholinesterase","volume":"80","author":"Boudinot","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.tox.2006.11.069_bib8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0022-3565(25)20479-7","article-title":"Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates","volume":"259","author":"Broomfield","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2006.11.069_bib9","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1021\/tx0499259","article-title":"Organophosphate toxicology: safety aspects of nonacetylcholinesterase secondary targets","volume":"17","author":"Casida","year":"2004","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tox.2006.11.069_bib10","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1046\/j.1460-9568.2003.02867.x","article-title":"Respiratory survival mechanisms in acetylcholinesterase knockout mouse","volume":"18","author":"Chatonnet","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.tox.2006.11.069_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrn1035","article-title":"Neurobiology of butyrylcholinesterase","volume":"4","author":"Darvesh","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tox.2006.11.069_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0165-1838(98)00064-2","article-title":"Cholinesterases in cardiac ganglia and modulation of canine intrinsic cardiac neuronal activity","volume":"71","author":"Darvesh","year":"1998","journal-title":"J. Auton. Nerv. Syst."},{"key":"10.1016\/j.tox.2006.11.069_bib13","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1083\/jcb.78.3.785","article-title":"Electron microscope localization of acetylcholinesterase and butyrylcholinesterase in the superior cervical ganglion of the cat. I. Normal ganglion","volume":"78","author":"Davis","year":"1978","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tox.2006.11.069_bib14","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1124\/jpet.102.033746","article-title":"Wild-type and A328W mutant human butyrylcholinesterase tetramers expressed in Chinese hamster ovary cells have a 16-hour half-life in the circulation and protect mice from cocaine toxicity","volume":"302","author":"Duysen","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2006.11.069_bib15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0022-3565(24)29259-4","article-title":"Evidence for nonacetylcholinesterase targets of organophosphorus nerve agent: supersensitivity of acetylcholinesterase knockout mouse to VX lethality","volume":"299","author":"Duysen","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2006.11.069_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-3806(02)00367-X","article-title":"Rescue of the acetylcholinesterase knockout mouse by feeding a liquid diet; phenotype of the adult acetylcholinesterase deficient mouse","volume":"137","author":"Duysen","year":"2002","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.tox.2006.11.069_bib17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2006.11.069_bib18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1124\/mol.104.006924","article-title":"Gene transfer of cocaine hydrolase suppresses cardiovascular responses to cocaine in rats","volume":"67","author":"Gao","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tox.2006.11.069_bib19","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/00000542-200109000-00010","article-title":"Response to mivacurium in a patient compound heterozygous for a novel and a known silent mutation in the butyrylcholinesterase gene: genotyping by sequencing","volume":"95","author":"Gatke","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.tox.2006.11.069_bib20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.phrs.2003.11.017","article-title":"Cholinesterase inhibitors: new roles and therapeutic alternatives","volume":"50","author":"Giacobini","year":"2004","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tox.2006.11.069_bib21","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/215322b0","article-title":"Hereditary deficiency of pseudocholinesterase in Eskimos","volume":"215","author":"Gutsche","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.tox.2006.11.069_bib22","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1172\/JCI105162","article-title":"Complete pseudocholinesterase deficiency: genetic and immunologic characterization","volume":"44","author":"Hodgkin","year":"1965","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tox.2006.11.069_bib23","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/jnnp.2004.039321","article-title":"Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation","volume":"76","author":"Holmes","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.tox.2006.11.069_bib24","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/0041-0101(94)90416-2","article-title":"Tissue distribution of human acetylcholinesterase and butyrylcholinesterase messenger RNA","volume":"32","author":"Jbilo","year":"1994","journal-title":"Toxicon"},{"key":"10.1016\/j.tox.2006.11.069_bib25","doi-asserted-by":"crossref","unstructured":"Li, B., Duysen, E.G., Saunders, T.L., Lockridge, O., 2006. Production of the butyrylcholinesterase knockout mouse. J. Mol. Neurosci.","DOI":"10.1385\/JMN:30:1:193"},{"key":"10.1016\/j.tox.2006.11.069_bib26","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.bcp.2005.09.002","article-title":"Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma","volume":"70","author":"Li","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2006.11.069_bib27","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1046\/j.1471-4159.2000.751320.x","article-title":"Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse","volume":"75","author":"Li","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tox.2006.11.069_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0163-7258(90)90044-3","article-title":"Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine","volume":"47","author":"Lockridge","year":"1990","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tox.2006.11.069_bib29","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.etap.2004.12.008","article-title":"Life without acetylcholinesterase: the implications of cholinesterase inhibitor toxicity in AChE-knockout mice","volume":"19","author":"Lockridge","year":"2005","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.tox.2006.11.069_bib30","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/01.fpc.0000197464.37211.77","article-title":"Naturally occurring mutation Leu307Pro of human butyrylcholinesterase in the Vysya community of India","volume":"16","author":"Manoharan","year":"2006","journal-title":"Pharmacogenet. Genom."},{"key":"10.1016\/j.tox.2006.11.069_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0079-6123(08)62391-2","article-title":"Structure and functions of acetylcholinesterase and butyrylcholinesterase","volume":"98","author":"Massoulie","year":"1993","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.tox.2006.11.069_bib32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0378-4274(87)90254-2","article-title":"The effect of carboxylesterase inhibition on interspecies differences in soman toxicity","volume":"39","author":"Maxwell","year":"1987","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tox.2006.11.069_bib33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0041-008X(87)90270-5","article-title":"The effects of blood flow and detoxification on in vivo cholinesterase inhibition by soman in rats","volume":"88","author":"Maxwell","year":"1987","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2006.11.069_bib34","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.neuropharm.2005.06.011","article-title":"Mefloquine inhibits cholinesterases at the mouse neuromuscular junction","volume":"49","author":"McArdle","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tox.2006.11.069_bib35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0892-0362(93)90065-V","article-title":"Utility of a neurobehavioral screening battery for differentiating the effects of two pyrethroids, permethrin and cypermethrin","volume":"15","author":"McDaniel","year":"1993","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.tox.2006.11.069_bib36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/nbdi.2001.0462","article-title":"Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain","volume":"9","author":"Mesulam","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tox.2006.11.069_bib37","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0306-4522(01)00613-3","article-title":"Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine","volume":"110","author":"Mesulam","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.tox.2006.11.069_bib38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.bjp.0705010","article-title":"Butyrylcholinesterase and acetylcholinesterase activity and quantal transmitter release at normal and acetylcholinesterase knockout mouse neuromuscular junctions","volume":"138","author":"Minic","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tox.2006.11.069_bib39","doi-asserted-by":"crossref","unstructured":"Morton, C.L., Iacono, L., Hyatt, J.L., Taylor, K.R., Cheshire, P.J., Houghton, P.J., Danks, M.K., Stewart, C.F., Potter, P.M., 2005. Activation and antitumor activity of CPT-11 in plasma esterase-deficient mice. Cancer Chemother. Pharmacol.","DOI":"10.1007\/s00280-005-1027-y"},{"key":"10.1016\/j.tox.2006.11.069_bib40","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0892-0362(95)02002-0","article-title":"Comparisons of the acute effects of cholinesterase inhibitors using a neurobehavioral screening battery in rats","volume":"17","author":"Moser","year":"1995","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.tox.2006.11.069_bib41","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1476-5381.1993.tb13486.x","article-title":"Degradation of acetylcholine in human airways: role of butyrylcholinesterase","volume":"108","author":"Norel","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tox.2006.11.069_bib42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00008571-200304000-00008","article-title":"Regulation of attention and response to therapy in dementia by butyrylcholinesterase","volume":"13","author":"O\u2019Brien","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.tox.2006.11.069_bib43","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/toxsci\/kfi023","article-title":"Albumin, a new biomarker of organophosphorus toxicant exposure, identified by mass spectrometry","volume":"83","author":"Peeples","year":"2005","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2006.11.069_bib44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/109374099281205","article-title":"Organophosphorus pesticides: do they all have the same mechanism of toxicity?","volume":"2","author":"Pope","year":"1999","journal-title":"J. Toxicol. Environ. Health B: Crit. Rev."},{"key":"10.1016\/j.tox.2006.11.069_bib45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00284608","article-title":"High incidence of the silent allele at cholinesterase locus 1 in Vysyas of Andrha Pradesh (S. India)","volume":"52","author":"Rao","year":"1979","journal-title":"Hum. Genet."},{"key":"10.1016\/j.tox.2006.11.069_bib46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/taap.1997.8160","article-title":"The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase","volume":"145","author":"Raveh","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2006.11.069_bib47","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0378-4274(01)00266-1","article-title":"The potential for toxic effects of chronic, low-dose exposure to organophosphates","volume":"120","author":"Ray","year":"2001","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tox.2006.11.069_bib48","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ymgme.2004.12.005","article-title":"Four new mutations in the BCHE gene of human butyrylcholinesterase in a Brazilian blood donor sample","volume":"84","author":"Souza","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.tox.2006.11.069_bib49","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00000542-198110000-00015","article-title":"Succinylcholine neuromuscular blockade in subjects homozygous for atypical plasma cholinesterase","volume":"55","author":"Viby-Mogensen","year":"1981","journal-title":"Anesthesiology"},{"key":"10.1016\/j.tox.2006.11.069_bib50","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0022-3565(24)39312-7","article-title":"Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase","volume":"293","author":"Xie","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X0600713X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X0600713X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:58:37Z","timestamp":1759532317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X0600713X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":50,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0300483X0600713X"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2006.11.069","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sensitivity of butyrylcholinesterase knockout mice to (\u2212)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2006.11.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}